Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention

被引：45
|
作者：
Grundy, Scott M. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dept Clin Nutr & Internal Med, Ctr Human Nutr, Dallas, TX 75390 USA
来源：
CIRCULATION | 2008年 / 117卷 / 04期
关键词：
D O I：
10.1161/CIRCULATIONAHA.107.720300
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：569 / 573
页数：5
相关论文
共 50 条
  • [21] New Strategies for Lowering Low-Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention
    Gaine, Sean Paul
    Quispe, Renato
    Patel, Jaideep
    Michos, Erin D.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (09) : 69 - 78
  • [22] Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy
    Tsutsumi, Z
    Moriwaki, Y
    Takahashi, S
    Ka, T
    Yamamoto, T
    CLINICA CHIMICA ACTA, 2004, 339 (1-2) : 117 - 122
  • [23] Effectiveness of the low-density lipoprotein cholesterol goals in secondary cardiovascular prevention
    Garcia-Gil, Maria
    Alves-Cabratosa, Lia
    Cunillera, Oriol
    Blanch, Jordi
    Marti-Lluch, Ruth
    Ponjoan, Anna
    Ribas-Aulinas, Francesc
    Tornabell-Noguera, Eric
    Zacarias-Pons, Lluis
    Dominguez-Armengol, Gina
    Guzman, Elizabeth
    Ramos, Rafel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)
  • [24] What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?
    Endo, A.
    Okada, T.
    Kagawa, Y.
    Sato, H.
    Morita, Y.
    Pak, M.
    Ouchi, T.
    Watanabe, N.
    Yamaguchi, K.
    Yoshitomi, H.
    Tanabe, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 251 - 251
  • [25] Low-density lipoprotein cholesterol lowering in the prevention of CHD: How low should we go?
    Isley W.L.
    Current Treatment Options in Cardiovascular Medicine, 2006, 8 (4) : 289 - 297
  • [26] The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?
    Khera, Amit V.
    Natarajan, Pradeep
    Kathiresan, Sekar
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1062 - 1064
  • [27] Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: Absolute levels or extent of lowering?
    Cullen, P
    Assmann, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (10): : 1287 - 1294
  • [28] Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering-lipoprotein changes and interactions: the SANDS study
    Howard, Wm. James
    Russell, Marie
    Fleg, Jerome L.
    Mete, Mihriye
    Ali, Tauqeer
    Devereux, Richard B.
    Galloway, James M.
    Otvos, James D.
    Ratner, Robert E.
    Roman, Mary J.
    Silverman, Angela
    Umans, Jason G.
    Weissman, Neil J.
    Wilson, Charlton
    Howard, Barbara V.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (05) : 322 - 331
  • [29] Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
    Packard, Chris
    Chapman, M. John
    Sibartie, Mahendra
    Laufs, Ulrich
    Masana, Luis
    HEART, 2021, 107 (17) : 1369 - 1375
  • [30] Low-density lipoprotein cholesterol lowering for the prevention of cardiovascular outcomes in patients with ischemic stroke
    Ntaios, George
    Milionis, Haralampos
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (05) : 476 - 482
12345